The Many Faces of FKBP51
Open accessThe DOI matches its Crossref record; 117 of the 118 references it cites were found in a registry or an index.
Abstract
The FK506-binding protein 51 (FKBP51) has emerged as a key regulator of endocrine stress responses in mammals and as a potential therapeutic target for stress-related disorders (depression, post-traumatic stress disorder), metabolic disorders (obesity and diabetes) and chronic pain. Recently, FKBP51 has been implicated in several cellular pathways and numerous interacting protein partners have been reported. However, no consensus on the underlying molecular mechanisms has yet emerged. Here, we review the protein interaction partners reported for FKBP51, the proposed pathways involved, their relevance to FKBP51’s physiological function(s), the interplay with other FKBPs, and implications for the development of FKBP51-directed drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The FK1 PPIase active site is comprised of a series of β strands that form a conserved hydrophobic pocket where immunosuppressive drugs bind, including FK506 and rapamycin”
From The structure of an Hsp90-immunophilin complex reveals cochaperone recognition of the client maturation state (2021) · cites this paper as Hahle et al., 2019
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Only minor differences between FKBP52 and FKBP51 are identified in the crystal structures due to changes in the FK2-TPR domain orientation”
From The structure of an Hsp90-immunophilin complex reveals cochaperone recognition of the client maturation state (2021) · cites this paper as Hahle et al., 2019
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology
Zhang, Q., Lenardo, M. J., & Baltimore, D. (2017) · Cell · doi:10.1016/j.cell.2016.12.012 · Cited by 1,982
Schopf, F. H., Biebl, M. M., & Buchner, J. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.20 · Cited by 1,540
Allele-specific FKBP5 DNA demethylation mediates gene–childhood trauma interactions
Klengel, T., Mehta, D., Anacker, C., Rex-Haffner, M., Pruessner, J. C., Pariante, C. M., Pace, T. W. W., Mercer, K. B., Mayberg, H. S., Bradley, B., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3275 · Cited by 1,447 · cited 2×
“Reduced methylation of this site was shown to allow for enhanced GR-induced transcription of FKBP5 [27].”
BackgroundStructure of TPR Domain–Peptide Complexes
Scheufler, C., Brinker, A., Bourenkov, G., Pegoraro, S., Moroder, L., Bartunik, H., Hartl, F. U., & Moarefi, I. (2000) · Cell · doi:10.1016/s0092-8674(00)80830-2 · Cited by 1,188 · cited 1×
“All of them share a 20 amino acid consensus sequence which is required for Hsp90 recognition [17,23], leading to a high competition for Hsp90 association which has been shown to be important for the regulation of steroid receptor signaling [53].”
BackgroundA physical and functional map of the human TNF-α/NF-κB signal transduction pathway
Bouwmeester, T., Bauch, A., Ruffner, H., Angrand, P.-O., Bergamini, G., Croughton, K., Cruciat, C., Eberhard, D., Gagneur, J., Ghidelli, S., et al. (2004) · Nature Cell Biology · doi:10.1038/ncb1086 · Cited by 1,029
Mitchell, S., Vargas, J., & Hoffmann, A. (2016) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1331 · Cited by 1,029
FKBP51 Affects Cancer Cell Response to Chemotherapy by Negatively Regulating Akt
Pei, H., Li, L., Fridley, B. L., Jenkins, G. D., Kalari, K. R., Lingle, W., Petersen, G., Lou, Z., & Wang, L. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.07.016 · Cited by 709
Wochnik, G. M., Rüegg, J., Abel, G. A., Schmidt, U., Holsboer, F., & Rein, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m407498200 · Cited by 638
Gene–Stress–Epigenetic regulation of FKBP5: clinical and translational implications
Zannas, A. S., Wiechmann, T., Gassen, N. C., & Binder, E. B. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.235 · Cited by 622 · cited 1×
“Moreover, numerous studies have linked the rs1360780 T allele or related FKBP51-hyperinduction haplotypes to a higher risk for disorders such as major depressive disorders, post-traumatic stress disorder, suicidality, aggression, psychosis, and cognitive performance [25,26].”
BackgroundTaipale, M., Tucker, G., Peng, J., Krykbaeva, I., Lin, Z.-Y., Larsen, B., Choi, H., Berger, B., Gingras, A.-C., & Lindquist, S. (2014) · Cell · doi:10.1016/j.cell.2014.05.039 · Cited by 392
The Hsp90‐binding peptidylprolyl isomerase FKBP52 potentiates glucocorticoid signaling in vivo
Riggs, D. L., Roberts, P. J., Chirillo, S. C., Cheung‐Flynn, J., Prapapanich, V., Ratajczak, T., Gaber, R., Picard, D., & Smith, D. F. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg108 · Cited by 353 · cited 2×
“GR via Hsp90 [58] SUMOylation dependent [22] FKBP52 competitive [70] PR b [58] d [58]”
BackgroundBrouillard, P., Boon, L. M., Mulliken, J. B., Enjolras, O., Ghassibé, M., Warman, M. L., Tan, O. T., Olsen, B. R., & Vikkula, M. (2002) · The American Journal of Human Genetics · doi:10.1086/339492 · Cited by 342
Noncanonical NF-κB Signaling in Health and Disease
Cildir, G., Low, K. C., & Tergaonkar, V. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.03.002 · Cited by 301
Progesterone Receptor Structure and Function Altered by Geldanamycin, an hsp90-Binding Agent
Smith, D. F., Whitesell, L., Nair, S. C., Chen, S., Prapapanich, V., & Rimerman, R. A. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.12.6804 · Cited by 289
Vermeer, H., Hendriks-Stegeman, B. I., van der Burg, B., van Buul-Offers, S. C., & Jansen, M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020354 · Cited by 285
Touma, C., Gassen, N. C., Herrmann, L., Cheung-Flynn, J., Büll, D. R., Ionescu, I. A., Heinzmann, J.-M., Knapman, A., Siebertz, A., Depping, A.-M., et al. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.07.023 · Cited by 273
Self-citationThe chaperone Hsp90: changing partners for demanding clients
Röhl, A., Rohrberg, J., & Buchner, J. (2013) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2013.02.003 · Cited by 269
Sinars, C. R., Cheung-Flynn, J., Rimerman, R. A., Scammell, J. G., Smith, D. F., & Clardy, J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0231020100 · Cited by 254 · cited 5×
“FKBP51 belongs to the larger FKBP proteins and consists of a FKBP-type peptidyl-prolyl cis-trans isomerase (PPIase) domain (called FK1), a FKBP-like domain (FK2) and a three-unit repeat of the tetratricopeptide repeat (TPR) domain (Figure 1) [1].”
BackgroundInfluentialSelective inhibitors of the FK506-binding protein 51 by induced fit
Gaali, S., Kirschner, A., Cuboni, S., Hartmann, J., Kozany, C., Balsevich, G., Namendorf, C., Fernandez-Vizarra, P., Sippel, C., Zannas, A. S., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1699 · Cited by 245 · cited 8×
“SAFit2 enhanced feedback inhibition of the hypothalamus–pituitary–adrenal axis [11], stress coping [11], and glucose tolerance [41]; was anxiolytic [33]; protected from weight gain [41]; and ameliorated mechanical hypersensitivity in inflammatory, neuropathic and chemotherapy-induced pain states [35,42].”
BackgroundInfluentialSelf-citationMolecular basis for TPR domain‐mediated regulation of protein phosphatase 5
Yang, J., Roe, S. M., Cliff, M. J., Williams, M. A., Ladbury, J. E., Cohen, P. T., & Barford, D. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600496 · Cited by 236
Molecular chaperones, essential partners of steroid hormone receptors for activity and mobility
Echeverria, P. C., & Picard, D. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.11.012 · Cited by 227
Matosin, N., Halldorsdottir, T., & Binder, E. B. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.01.021 · Cited by 226 · cited 1×
“Moreover, numerous studies have linked the rs1360780 T allele or related FKBP51-hyperinduction haplotypes to a higher risk for disorders such as major depressive disorders, post-traumatic stress disorder, suicidality, aggression, psychosis, and cognitive performance [25,26].”
BackgroundHartmann, J., Wagner, K. V., Liebl, C., Scharf, S. H., Wang, X.-D., Wolf, M., Hausch, F., Rein, T., Schmidt, U., Touma, C., et al. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.07.041 · Cited by 224
Self-citationSmith, D. F., Faber, L. E., & Toft, D. O. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39693-0 · Cited by 221 · cited 1×
“In early studies on steroid hormone receptors, FKBP51 and 52 (firstly entitled as p50 and p54) were successfully co-purified along with Hsp90 and the progesterone receptor [47] and later on were identified as immunophilins of the FKBP family [48].”
BackgroundThe Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules
Jinwal, U. K., Koren, J., Borysov, S. I., Schmid, A. B., Abisambra, J. F., Blair, L. J., Johnson, A. G., Jones, J. R., Shults, C. L., O'Leary, J. C., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4815-09.2010 · Cited by 214
Expression and Regulation of the Fkbp5 Gene in the Adult Mouse Brain
Scharf, S. H., Liebl, C., Binder, E. B., Schmidt, M. V., & Müller, M. B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016883 · Cited by 202
Intronic hormone response elements mediate regulation of FKBP5 by progestins and glucocorticoids
Hubler, T. R., & Scammell, J. G. (2004) · Cell Stress & Chaperones · doi:10.1379/csc-32r.1 · Cited by 201
Barent, R. L., Nair, S. C., Carr, D. C., Ruan, Y., Rimerman, R. A., Fulton, J., Zhang, Y., & Smith, D. F. (1998) · Molecular Endocrinology · doi:10.1210/mend.12.3.0075 · Cited by 190 · cited 2×
“Both FKBP51 and its PPIase-deficient mutant are preferentially associated with PR and GR [58].”
BackgroundChen, S., Sullivan, W. P., Toft, D. O., & Smith, D. F. (1998) · Cell Stress and Chaperones · doi:10.1379/1466-1268(1998)003<0256:ealocb>2.3.co;2 · Cited by 189
Pirkl, F., & Buchner, J. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4595 · Cited by 179 · cited 1×
“The differences in binding affinity and concentration of various TPR-domain proteins [54] reflect one layer to regulate the action of FKBP51 [55].”
BackgroundGassen, N. C., Hartmann, J., Zschocke, J., Stepan, J., Hafner, K., Zellner, A., Kirmeier, T., Kollmannsberger, L., Wagner, K. V., Dedic, N., et al. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001755 · Cited by 177
Menke, A., Arloth, J., Pütz, B., Weber, P., Klengel, T., Mehta, D., Gonik, M., Rex-Haffner, M., Rubel, J., Uhr, M., et al. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.331 · Cited by 177 · cited 1×
“In humans, robust glucocorticoid-induced expression of FKBP51 has been observed in blood cells [31] and biopsies from skin [32] and adipose tissue [28].”
BackgroundMayer, M. P., & Le Breton, L. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.02.022 · Cited by 174
Wu, B., Li, P., Liu, Y., Lou, Z., Ding, Y., Shu, C., Ye, S., Bartlam, M., Shen, B., & Rao, Z. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0305969101 · Cited by 165
Mixed Hsp90–cochaperone complexes are important for the progression of the reaction cycle
Li, J., Richter, K., & Buchner, J. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1965 · Cited by 155
Ni, L., Yang, C.-S., Gioeli, D., Frierson, H., Toft, D. O., & Paschal, B. M. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01891-08 · Cited by 155 · cited 1×
“Contrary to GR, where FKBP51 has repeatedly been described as an inhibitory factor, two studies in 2010 reported an activation of AR by FKBP51 [74,75].”
BackgroundRomano, M. F., Avellino, R., Petrella, A., Bisogni, R., Romano, S., & Venuta, S. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.08.017 · Cited by 154
Riggs, D. L., Cox, M. B., Tardif, H. L., Hessling, M., Buchner, J., & Smith, D. F. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00985-07 · Cited by 150 · cited 3×
“Pro119 as in FKBP52 supported receptor activation whereas L119 as in FKBP51 was inhibitory [15].”
BackgroundAmler, L. C., Agus, D. B., LeDuc, C. A., Sapinoso, M. L., Fox, W. D., Kern, S. G., Lee, D., Wang, V., Leysens, M., Higgins, B., et al. (2000) · PubMed · Cited by 149
Brouillard, P., Ghassibe‐Sabbagh, M., Penington, A., Boon, L. M., Dompmartin, A., Temple, I. K., Cordisco, M., Adams, D., Piette, F., Harper, J. I., et al. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.024174 · Cited by 146
Hubler, T. R., Denny, W. B., Valentine, D. L., Cheung-Flynn, J., Smith, D. F., & Scammell, J. G. (2003) · Endocrinology · doi:10.1210/en.2003-0092 · Cited by 145
Large FK506-binding proteins shape the pharmacology of rapamycin
März, A. M., Fabian, A.-K., Kozany, C., Bracher, A., & Hausch, F. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00678-12 · Cited by 141
Self-citationRole of FK506-binding protein 51 in the control of apoptosis of irradiated melanoma cells
Romano, S., D'Angelillo, A., Pacelli, R., Staibano, S., Luna, E. D., Bisogni, R., Eskelinen, E., Mascolo, M., Calì, G., Arra, C., et al. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.115 · Cited by 138
Baughman, G., Wiederrecht, G., Chang, F., Martin, M. M., & Bourgeois, S. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6307 · Cited by 138
Stress-responsive FKBP51 regulates AKT2-AS160 signaling and metabolic function
Balsevich, G., Häusl, A. S., Meyer, C. W., Karamihalev, S., Feng, X., Pöhlmann, M. L., Dournes, C., Uribe-Marino, A., Santarelli, S., Labermaier, C., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01783-y · Cited by 134 · cited 11×
“(AS160) was coimmunoprecipitated along with FKBP51, Akt and PHLPP [41].”
BackgroundSelf-citationKester, H. A., van der Leede, B.-J. M., van der Saag, P. T., & van der Burg, B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.26.16637 · Cited by 130
Zhu, W. (2001) · Carcinogenesis · doi:10.1093/carcin/22.9.1399 · Cited by 124
Mousses, S., Wagner, U., Chen, Y., Kim, J. W., Bubendorf, L., Bittner, M. L., Pretlow, T. G., ELKAHLOUN, A. G., Trepel, J. B., & Kallioniemi, O. (2001) · Oncogene · doi:10.1038/sj.onc.1204889 · Cited by 123
A New Anti-Depressive Strategy for the Elderly: Ablation of FKBP5/FKBP51
O'Leary, J. C., Dharia, S., Blair, L. J., Brady, S., Johnson, A. G., Peters, M., Cheung-Flynn, J., Cox, M. B., de Erausquin, G., Weeber, E. J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024840 · Cited by 122
Glucocorticoid receptor activates poised FKBP51 locus through long-distance interactions
Paakinaho, V., Makkonen, H., Jääskeläinen, T., & Palvimo, J. J. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0443 · Cited by 122 · cited 1×
“The FKBP5 gene contains several glucocorticoid receptor response elements, and GR attachment mediates RNA polymerase II (PolII) loading and DNA methylation [69].”
BackgroundWilson, K. P., Yamashita, M. M., Sintchak, M. D., Rotstein, S. H., Murcko, M. A., Boger, J., Thomson, J. A., Fitzgibbon, M. J., Black, J. R., & Navia, M. A. (1995) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994014514 · Cited by 117
Pereira, M. J., Palming, J., Svensson, M. K. E., Rizell, M., Dalenbäck, J., Hammar, M., Fall, T., Sidibeh, C. O., Svensson, P., & Eriksson, J. W. (2014) · Metabolism · doi:10.1016/j.metabol.2014.05.015 · Cited by 112
Assimon, V. A., Southworth, D. R., & Gestwicki, J. E. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b00801 · Cited by 112
Pharmacological Inhibition of the Psychiatric Risk Factor FKBP51 Has Anxiolytic Properties
Hartmann, J., Wagner, K. V., Gaali, S., Kirschner, A., Kozany, C., Ruhter, G., Dedic, N., Hausl, A. S., Hoeijmakers, L., Westerholz, S., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.4024-14.2015 · Cited by 109 · cited 2×
“In the rodent brain, basal FKBP51 expression is highest in the hippocampus, but strong induction of FKBP51 was observed in the amygdala and the paraventricular nucleus of the hypothalamus after a stress or glucocorticoid challenge [33,34].”
BackgroundSelf-citationPeriyasamy, S., Hinds, T., Shemshedini, L., Shou, W., & Sanchez, E. R. (2010) · Oncogene · doi:10.1038/onc.2009.458 · Cited by 108 · cited 1×
“Contrary to GR, where FKBP51 has repeatedly been described as an inhibitory factor, two studies in 2010 reported an activation of AR by FKBP51 [74,75].”
BackgroundUSP49 negatively regulates tumorigenesis and chemoresistance through FKBP51‐AKT signaling
Luo, K., Li, Y., Yin, Y., Li, L., Wu, C., Chen, Y., Nowsheen, S., Hu, Q., Zhang, L., Lou, Z., et al. (2017) · The EMBO Journal · doi:10.15252/embj.201695669 · Cited by 108
Gassen, N. C., Fries, G. R., Zannas, A. S., Hartmann, J., Zschocke, J., Hafner, K., Carrillo-Roa, T., Steinbacher, J., Preißinger, S. N., Hoeijmakers, L., et al. (2015) · Science Signaling · doi:10.1126/scisignal.aac7695 · Cited by 107
Association of Immunophilins with Mammalian TRPC Channels
Sinkins, W. G., Goel, M., Estacion, M., & Schilling, W. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401156200 · Cited by 105
Differential Impact of Tetratricopeptide Repeat Proteins on the Steroid Hormone Receptors
Schülke, J.-P., Wochnik, G. M., Lang-Rollin, I., Gassen, N. C., Knapp, R. T., Berning, B., Yassouridis, A., & Rein, T. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011717 · Cited by 105
The stress regulator FKBP51 drives chronic pain by modulating spinal glucocorticoid signaling
Maiarù, M., Tochiki, K. K., Cox, M. B., Annan, L. V., Bell, C. G., Feng, X., Hausch, F., & Géranton, S. M. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aab3376 · Cited by 104
Self-citationRegulation of Serine-Threonine Kinase Akt Activation by NAD+-Dependent Deacetylase SIRT7
Yu, J., Qin, B., Wu, F., Qin, S., Nowsheen, S., Shan, S., Zayas, J., Pei, H., Lou, Z., & Wang, L. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.01.009 · Cited by 104
Sidibeh, C. O., Pereira, M. J., Abalo, X. M., J. Boersma, G., Skrtic, S., Lundkvist, P., Katsogiannos, P., Hausch, F., Castillejo-López, C., & Eriksson, J. W. (2018) · Endocrine · doi:10.1007/s12020-018-1674-5 · Cited by 104
Self-citationAge-Associated Epigenetic Upregulation of the FKBP5 Gene Selectively Impairs Stress Resiliency
Sabbagh, J. J., O'Leary, J. C., Blair, L. J., Klengel, T., Nordhues, B. A., Fontaine, S. N., Binder, E. B., & Dickey, C. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107241 · Cited by 101
Structure and pro-toxic mechanism of the human Hsp90/PPIase/Tau complex
Oroz, J., Chang, B. J., Wysoczanski, P., Lee, C.-T., Pérez-Lara, Á., Chakraborty, P., Hofele, R. V., Baker, J. D., Blair, L. J., Biernat, J., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06880-0 · Cited by 100
NF-κB Transcriptional Activity Is Modulated by FK506-binding Proteins FKBP51 and FKBP52
Erlejman, A. G., De Leo, S. A., Mazaira, G. I., Molinari, A. M., Camisay, M. F., Fontana, V., Cox, M. B., Piwien-Pilipuk, G., & Galigniana, M. D. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.582882 · Cited by 97
Cheung-Flynn, J., Roberts, P. J., Riggs, D. L., & Smith, D. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300955200 · Cited by 96
Fluorescent Probes to Characterise FK506‐Binding Proteins
Kozany, C., März, A., Kress, C., & Hausch, F. (2009) · ChemBioChem · doi:10.1002/cbic.200800806 · Cited by 91
Self-citationJiang, W., Cazacu, S., Xiang, C., Zenklusen, J. C., Fine, H. A., Berens, M., Armstrong, B., Brodie, C., & Mikkelsen, T. (2008) · Neoplasia · doi:10.1593/neo.07929 · Cited by 88 · cited 9×
“proposed that the FK1 domain is involved in the interaction with IKKα in human glioma cells (U87) [83].”
BackgroundResultInfluentialFKBP51 Null Mice Are Resistant to Diet-Induced Obesity and the PPARγ Agonist Rosiglitazone
Stechschulte, L. A., Qiu, B., Warrier, M., Hinds, T. D., Zhang, M., Gu, H., Xu, Y., Khuder, S. S., Russo, L., Najjar, S. M., et al. (2016) · Endocrinology · doi:10.1210/en.2015-1996 · Cited by 88
Amler, L. C., Agus, D. B., LeDuc, C., Sapinoso, L. M., Fox, W., Kern, S. G., Lee, D., Wang, V. Y., Leysens, M., Higgins, B., et al. (2001) · Nature Genetics · doi:10.1038/86980 · Cited by 85
Quintá, H. R., Maschi, D., Gomez‐Sanchez, C., Piwien‐Pilipuk, G., & Galigniana, M. D. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06970.x · Cited by 85
FKBP51 employs both scaffold and isomerase functions to promote NF-κB activation in melanoma
Romano, S., Xiao, Y., Nakaya, M., D'Angelillo, A., Chang, M., Jin, J., Hausch, F., Masullo, M., Feng, X., Romano, M. F., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv615 · Cited by 82
Self-citationHinz, M., Broemer, M., Arslan, S. Ç., Otto, A., Mueller, E.-C., Dettmer, R., & Scheidereit, C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705785200 · Cited by 76
Genotypes and Phenotypes of 162 Families with a Glomulin Mutation
Brouillard, P., Boon, L. M., Revençu, N., Berg, J., Dompmartin, A., Dubois, J., Garzón, M. C., Holden, S. T., Kangesu, L., Labrèze, C., et al. (2013) · Molecular Syndromology · doi:10.1159/000348675 · Cited by 75
FAP48, a New Protein That Forms Specific Complexes with Both Immunophilins FKBP59 and FKBP12
Chambraud, B., Radanyi, C., Camonis, J. H., Shazand, K., Rajkowski, K., & Baulieu, E.-E. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.51.32923 · Cited by 73
FKBP54, a novel FK506-binding protein in avian progesterone receptor complexes and HeLa extracts.
Smith, D. F., Albers, M. W., Schreiber, S. L., Leach, K. L., & Deibel, M. R. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80520-1 · Cited by 72
Bortsov, A. V., Smith, J. E., Diatchenko, L., Soward, A. C., Ulirsch, J. C., Rossi, C., Swor, R. A., Hauda, W. E., Peak, D. A., Jones, J. S., et al. (2013) · Pain · doi:10.1016/j.pain.2013.04.037 · Cited by 69
Glucocorticoid receptor function in health and disease
Caratti, G., Matthews, L., Poolman, T., Kershaw, S., Baxter, M., & Ray, D. (2015) · Clinical Endocrinology · doi:10.1111/cen.12728 · Cited by 66
Linnstaedt, S. D., Riker, K. D., Rueckeis, C. A., Kutchko, K. M., Lackey, L., McCarthy, K. R., Tsai, Y.-H., Parker, J. S., Kurz, M. C., Hendry, P. L., et al. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.3458-17.2018 · Cited by 66
Evaluation of synthetic FK506 analogues as ligands for the FK506-binding proteins 51 and 52
Gopalakrishnan, R., Kozany, C., Gaali, S., Kress, C., Hoogeland, B., Bracher, A., & Hausch, F. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201746x · Cited by 64 · cited 3×
“Based on co-crystal structures [4,7] and a fluorescence-based competitive binding assay [5], we performed a first systematic analysis of the binding requirements for the FK506-binding site of FKBP51 [8,113], which led to simplified pipecolate scaffolds such as Cmpd 42 [8,113] (Figure 5).”
BackgroundMethodSelf-citationInterleukin-8 is a key mediator of FKBP51-induced melanoma growth, angiogenesis and metastasis
Srivastava, S. K., Bhardwaj, A., Arora, S., Tyagi, N., Singh, A. P., Carter, J. E., Scammell, J. G., Fodstad, Ø., & Singh, S. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.154 · Cited by 62
FKBP51 inhibits GSK3β and augments the effects of distinct psychotropic medications
Gassen, N. C., Hartmann, J., Zannas, A. S., Kretzschmar, A., Zschocke, J., Maccarrone, G., Hafner, K., Zellner, A., Kollmannsberger, L. K., Wagner, K. V., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.38 · Cited by 62 · cited 4×
“Both immunophillins were co-purified with the CDK5 and its downstream target DNA methyltransferase 1 (DNMT1) [82,95].”
BackgroundInfluentialFKBP51 Controls Cellular Adipogenesis through p38 Kinase-Mediated Phosphorylation of GRα and PPARγ
Stechschulte, L. A., Hinds, T. D., Khuder, S. S., Shou, W., Najjar, S. M., & Sánchez, E. R. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1022 · Cited by 62
Structural characterization of the PPIase domain of FKBP51, a cochaperone of human Hsp90
Bracher, A., Kozany, C., Thost, A.-K., & Hausch, F. (2011) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444911013862 · Cited by 62 · cited 5×
“Both ligands bind to FKBP51 in a similar fashion as to FKBP12 and exploit similar key interactions comprising hydrogen bonds with tyrosine 113 and the backbone amide of isoleucine 87 [6,7].”
BackgroundMethodInfluentialSelf-citationChemogenomic Profiling of Human and Microbial FK506-Binding Proteins
Pomplun, S., Sippel, C., Hähle, A., Tay, D., Shima, K., Klages, A., Ünal, C. M., Rieß, B., Toh, H. T., Hansen, G., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00137 · Cited by 62
Self-citationMaiarù, M., Morgan, O. B., Mao, T., Breitsamer, M., Bamber, H., Pöhlmann, M., Schmidt, M. V., Winter, G., Hausch, F., & Géranton, S. M. (2018) · Pain · doi:10.1097/j.pain.0000000000001204 · Cited by 62
Self-citationFKBP51 modulates steroid sensitivity and NFκB signalling: A novel anti‐inflammatory drug target
Kästle, M., Kistler, B., Lamla, T., Bretschneider, T., Lamb, D., Nicklin, P., & Wyatt, D. (2018) · European Journal of Immunology · doi:10.1002/eji.201847699 · Cited by 61
Increasing the efficiency of ligands for FK506-binding protein 51 by conformational control
Wang, Y., Kirschner, A., Fabian, A.-K., Gopalakrishnan, R., Kress, C., Hoogeland, B., Koch, U., Kozany, C., Bracher, A., & Hausch, F. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400087k · Cited by 60
Self-citationExploration of pipecolate sulfonamides as binders of the FK506-binding proteins 51 and 52
Gopalakrishnan, R., Kozany, C., Wang, Y., Schneider, S., Hoogeland, B., Bracher, A., & Hausch, F. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201747c · Cited by 52 · cited 2×
“Based on co-crystal structures [4,7] and a fluorescence-based competitive binding assay [5], we performed a first systematic analysis of the binding requirements for the FK506-binding site of FKBP51 [8,113], which led to simplified pipecolate scaffolds such as Cmpd 42 [8,113] (Figure 5).”
MethodSelf-citationThe co-chaperones Fkbp4/5 control Argonaute2 expression and facilitate RISC assembly
Martinez, N. J., Chang, H.-M., Borrajo, J. D. R., & Gregory, R. I. (2013) · RNA · doi:10.1261/rna.040790.113 · Cited by 51
InterAKTions with FKBPs - Mutational and Pharmacological Exploration
Fabian, A.-K., März, A., Neimanis, S., Biondi, R. M., Kozany, C., & Hausch, F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057508 · Cited by 48
Self-citationSabbagh, J. J., Cordova, R. A., Zheng, D., Criado-Marrero, M., Lemus, A., Li, P., Baker, J. D., Nordhues, B. A., Darling, A. L., Martinez-Licha, C., et al. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.8b00454 · Cited by 48 · cited 1×
“Recently, benztropine was claimed to diminish the inhibitory effect of FKBP51 on GR but the molecular mechanism of this remains to be elucidated [73].”
BackgroundEbong, I.-O., Beilsten-Edmands, V., Patel, N. A., Morgner, N., & Robinson, C. V. (2016) · Cell Discovery · doi:10.1038/celldisc.2016.2 · Cited by 47
Albu, S., Romanowski, C. P. N., Letizia Curzi, M., Jakubcakova, V., Flachskamm, C., Gassen, N. C., Hartmann, J., Schmidt, M. V., Schmidt, U., Rein, T., et al. (2014) · Journal of Sleep Research · doi:10.1111/jsr.12112 · Cited by 46
Self-citationBracher, A., Kozany, C., Hähle, A., Wild, P., Zacharias, M., & Hausch, F. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.07.041 · Cited by 45
Self-citationAkiyama, T., Shiraishi, T., Qin, J., Konno, H., Akiyama, N., Shinzawa, M., Miyauchi, M., Takizawa, N., Yanai, H., Ohashi, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095992 · Cited by 45
Pöhlmann, M. L., Häusl, A. S., Harbich, D., Balsevich, G., Engelhardt, C., Feng, X., Breitsamer, M., Hausch, F., Winter, G., & Schmidt, M. V. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00262 · Cited by 41
Self-citationKumar, R., Moche, M., Winblad, B., & Pavlov, P. F. (2017) · Scientific Reports · doi:10.1038/s41598-017-14731-z · Cited by 40
Structure–Affinity Relationship Analysis of Selective FKBP51 Ligands
Feng, X., Sippel, C., Bracher, A., & Hausch, F. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00785 · Cited by 39
Self-citationGaali, S., Feng, X., Hähle, A., Sippel, C., Bracher, A., & Hausch, F. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01355 · Cited by 37
Self-citationReynolds, P. D., Roveda, K. P., Tucker, J. A., Moore, C. M., Valentine, D. L., & Scammell, J. G. (1998) · PubMed · Cited by 36
Pomplun, S. J., Wang, Y., Kirschner, A., Kozany, C., Bracher, A., & Hausch, F. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201408776 · Cited by 36
Self-citationThe structure of FKBP38 in complex with the MEEVD tetratricopeptide binding-motif of Hsp90
Blundell, K. L. I. M., Pal, M., Roe, S. M., Pearl, L. H., & Prodromou, C. (2017) · PLOS ONE · doi:10.1371/journal.pone.0173543 · Cited by 36
The activity of the glucocorticoid receptor is regulated by SUMO conjugation to FKBP51
Antunica-Noguerol, M., Budziñski, M. L., Druker, J., Gassen, N. C., Sokn, C., Senin, S. A., Aprile-Garcia, F., Holsboer, F., Rein, T., Liberman, A. C., et al. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.44 · Cited by 34
Bischoff, M., Sippel, C., Bracher, A., & Hausch, F. (2014) · Organic Letters · doi:10.1021/ol5023195 · Cited by 31
Self-citationJirawatnotai, S., Sharma, S., Michowski, W., Suktitipat, B., Geng, Y., Quackenbush, J. F., Elias, J. E., Gygi, S. P., Wang, Y. E., & Siciński, P. (2014) · Cell Cycle · doi:10.4161/15384101.2014.946850 · Cited by 30
Baida, G. E., Bhalla, P., Yemelyanov, A. Y., Stechschulte, L. A., Shou, W., Readhead, B., Dudley, J. T., Sánchez, E. R., & Budunova, I. V. (2018) · Oncotarget · doi:10.18632/oncotarget.26194 · Cited by 30
FKBP52 is involved in the regulation of SOCE channels in the human platelets and MEG 01 cells
López, E., Berna‐Erro, A., Salido, G. M., Rosado, J. A., & Redondo, P. C. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.11.029 · Cited by 27
Mustafi, S. M., LeMaster, D. M., & Hernández, G. (2014) · Biochemical Journal · doi:10.1042/bj20140232 · Cited by 25
Wan, Y., & Nordeen, S. K. (2002) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0280177 · Cited by 23
LeMaster, D. M., Mustafi, S. M., Brecher, M. B., Zhang, J., Heroux, A., Li, H., & Hernández, G. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.650655 · Cited by 21
Regulation of store-operated calcium entry by FK506-binding immunophilins
Kadeba, P. I., Vasauskas, A. A., Chen, H., Wu, S., Scammell, J. G., & Cioffi, D. L. (2013) · Cell Calcium · doi:10.1016/j.ceca.2012.12.008 · Cited by 17
Conformational Dynamics in FKBP Domains: Relevance to Molecular Signaling and Drug Design
LeMaster, D. M., & Hernández, G. (2015) · Current Molecular Pharmacology · doi:10.2174/1874467208666150519113146 · Cited by 15
FKBP25 and FKBP38 regulate non-capacitative calcium entry through TRPC6
López, E., Berna‐Erro, A., Salido, G. M., Rosado, J. A., & Redondo, P. C. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.07.023 · Cited by 12
Serine/threonine phosphatase 5 (PP5C/PPP5C) regulates the ISOC channel through a PP5C‐FKBP51 axis
Hamilton, C. L., Abney, K. A., Vasauskas, A. A., ALEXEYEV, M. F., Ni, L., Honkanen, R. E., Scammell, J. G., & Cioffi, D. L. (2017) · Pulmonary Circulation · doi:10.1177/2045893217753156 · Cited by 12
Neye, H. (2001) · Regulatory Peptides · doi:10.1016/s0167-0115(00)00206-8 · Cited by 9
Lopez, E., Erro, A. R. B., Hernández-Cruz, J. M., Salido, G. M., Redondo, P. C., & Rosado, J. A. (2013) · Current Medicinal Chemistry · doi:10.2174/0929867311320140008 · Cited by 6
Cited by
Федотчева, Т. А., Fedotcheva, N. I., & Shimanovsky, N. L. (2022) · Biomolecules · doi:10.3390/biom12091299 · Cited by 157
Lee, K., Thwin, A. C., Nadel, C. M., Tse, E., Gates, S. N., Gestwicki, J. E., & Southworth, D. R. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.07.023 · Cited by 76
FKBP51 and the molecular chaperoning of metabolism
Smedlund, K., Sánchez, E. R., & Hinds, T. D. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.08.003 · Cited by 81
Malekpour, M., Shekouh, D., Safavinia, M. E., Shiralipour, S., Jalouli, M., Mortezanejad, S., Azarpira, N., & Ebrahimi, N. D. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1182345 · Cited by 85
Kamble, P. G., Hetty, S., Vranic, M., Almby, K. E., Castillejo-López, C., Abalo, X. M., Pereira, M. J., & Eriksson, J. W. (2020) · Scientific Reports · doi:10.1038/s41598-020-67293-y · Cited by 65
Metadata
- Authors
- Hähle, A., Merz, S., Meyners, C., & Hausch, F.
- Affiliations
- Technische Universität Darmstadt (DE)
- Corresponding author
- Hausch, Felix
- Venue
- Biomolecules
- Publisher
- MDPI AG
- Published
- 2019-01-21
- Volume
- 9
- Issue
- 1
- Pages
- 35
- ISSN
- 2218-273X (ISSN-L)
- PMC
- PMC6359276
- OpenAlex
- W2908829978
- Cited by
- 119
- References
- 118
- Citations by year
- 2026: 10 · 2025: 17 · 2024: 10 · 2023: 29 · 2022: 12 · 2021: 20 · 2020: 11 · 2019: 10
- FWCI
- 1.21
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Biomolecules (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- TUbilio (Technical University of Darmstadt) (submittedVersion)
- Technischen Universität Darmstadt (submittedVersion)
- Funders
- Bundesministerium für Bildung und Forschung (031B0269B)
- Bayerisches Staatsministerium für Wirtschaft und Medien, Energie und Technologie (BIO-1601-0003)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- FKBP51, FKBP, protein-protein interaction, endocrine stress response, depression, post-traumatic stress disorder, obesity, diabetes mellitus, chronic pain, therapeutic target, molecular mechanisms
- MeSH terms
- Tacrolimus Binding Protein 5, Glucocorticoids, Humans, Metabolic Diseases, Receptors, Steroid, Stress Disorders, Post-Traumatic, NF-kappa B, HSP90 Heat-Shock Proteins, Tacrolimus Binding Proteins, Proto-Oncogene Proteins c-akt
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.